Cargando…

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease

Biomarkers are the only feasible way to detect and monitor presymptomatic Alzheimer's disease (AD). No single biomarker can predict future cognitive decline with an acceptable level of accuracy. In addition to designing powerful multimodal diagnostic platforms, a careful investigation of the ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Apostolova, Liana G., Hwang, Kristy S., Kohannim, Omid, Avila, David, Elashoff, David, Jack, Clifford R., Shaw, Leslie, Trojanowski, John Q., Weiner, Michael W., Thompson, Paul M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952354/ https://www.ncbi.nlm.nih.gov/pubmed/24634832 http://dx.doi.org/10.1016/j.nicl.2013.12.012

Ejemplares similares

Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding
por: Lazaris, Andreas, et al.
Publicado: (2015)

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
por: Risacher, Shannon L., et al.
Publicado: (2013)

Multilocus genetic profiling to empower drug trials and predict brain atrophy()
por: Kohannim, Omid, et al.
Publicado: (2013)

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers
por: Schuff, N., et al.
Publicado: (2009)

Automated and manual hippocampal segmentation techniques: Comparison of results, reproducibility and clinical applicability
por: Hurtz, Sona, et al.
Publicado: (2018)

Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer’s disease
por: Nho, Kwangsik, et al.
Publicado: (2017)

Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment
por: Goukasian, Naira, et al.
Publicado: (2019)

Increased hippocampal activation in ApoE-4 carriers and non-carriers with amnestic mild cognitive impairment
por: Tran, Tammy T., et al.
Publicado: (2016)

Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid
por: Falahati, Farshad, et al.
Publicado: (2017)

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease
por: Jack, Clifford R., et al.
Publicado: (2010)

Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment
por: Clark, David Glenn, et al.
Publicado: (2016)

A comparison of theoretical and statistically derived indices for predicting cognitive decline
por: Wilhalme, Holly, et al.
Publicado: (2016)

Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment()
por: Rajagopalan, Priya, et al.
Publicado: (2012)

The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study
por: Paranjpe, Manish D., et al.
Publicado: (2019)

Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment
por: Toledo, Jon B, et al.
Publicado: (2014)

Applying surface-based hippocampal morphometry to study APOE-E4 allele dose effects in cognitively unimpaired subjects
por: Dong, Qunxi, et al.
Publicado: (2019)

Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers()()
por: Da, Xiao, et al.
Publicado: (2013)

Modeling of laser-induced breakdown spectroscopic data analysis by an automatic classifier
por: Pokrajac, David D., et al.
Publicado: (2019)

ApoE influences regional white-matter axonal density loss in Alzheimer's disease
por: Slattery, Catherine F., et al.
Publicado: (2017)

Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's disease
por: Brown, Christopher A, et al.
Publicado: (2016)

ARTS: A novel In-vivo classifier of arteriolosclerosis for the older adult brain
por: Makkinejad, Nazanin, et al.
Publicado: (2021)

Ensemble of a subset of kNN classifiers
por: Gul, Asma, et al.
Publicado: (2016)

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition
por: Toledo, Jon B, et al.
Publicado: (2014)

Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes
por: Vasilevskaya, Anna, et al.
Publicado: (2020)

Multilocus Genetic Analysis of Brain Images
por: Hibar, Derrek P., et al.
Publicado: (2011)

Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer’s disease
por: Ko, Yi-An, et al.
Publicado: (2022)

Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
por: Arnold, Matthias, et al.
Publicado: (2020)

Cognitive and neural signatures of the APOE E4 allele in mid-aged adults
por: Evans, Simon, et al.
Publicado: (2014)

Clinical Findings Associated with a De Novo Partial Trisomy 10p11.22p15.3 and Monosomy 7p22.3 Detected by Chromosomal Microarray Analysis
por: Kohannim, Omid, et al.
Publicado: (2011)

APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment
por: Dixon, Roger A., et al.
Publicado: (2014)

APOE gene-dependent BOLD responses to a breath-hold across the adult lifespan
por: Rasmussen, Peter M., et al.
Publicado: (2019)

Classifying heterogeneous presentations of PTSD via the default mode, central executive, and salience networks with machine learning
por: Nicholson, Andrew A., et al.
Publicado: (2020)

Interaction of APOE e4 and poor glycemic control predicts white matter hyperintensity growth from 73 to 76
por: Cox, Simon R., et al.
Publicado: (2017)

Temporal stability of the ventral attention network and general cognition along the Alzheimer’s disease spectrum
por: Chumin, Evgeny J., et al.
Publicado: (2021)

Event-based modeling of T1-weighted MRI is related to pathology in frontotemporal lobar degeneration due to tau and TDP
por: Olm, Christopher A., et al.
Publicado: (2022)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
por: Vemuri, Prashanthi, et al.
Publicado: (2011)

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
por: Kimura, M, et al.
Publicado: (1999)

Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity
por: Duara, R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k4q626hm418hh0s0mhgvqb8g3s